Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs

Am Heart J. 1979 Sep;98(3):345-50. doi: 10.1016/0002-8703(79)90047-4.

Abstract

Effects of antiarrhythmic drugs upon the threshold delivered energy (TDE) and threshold peak current (TPC) for electrical ventricular defibrillation by damped sinusoidal shocks were investigated in 25 pentobarbital-anesthetized dogs. TDE and TPC were increased by the three antiarrhytmic drugs tested. Bolus injections produced a transient rise and continuous infusions produced a steady rise in difibrillation threshold. The maximal percent elevations in mean defibrillation threshold during the 60 minutes after intravenous drug treatment in groups of n = 5 dogs were: (formula: see text). Accordingly, individuals receiving antiarrhythmic drugs who nonetheless fibrillate may require greater electric shock strength for defibrillation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / pharmacology*
  • Blood Pressure / drug effects
  • Dogs
  • Lidocaine / pharmacology
  • Phenytoin / pharmacology
  • Quinidine / pharmacology
  • Ventricular Fibrillation / physiopathology*

Substances

  • Anti-Arrhythmia Agents
  • Phenytoin
  • Lidocaine
  • Quinidine